A huge number of genetic studies have been conducted to elucidate the molecular mechanisms of T2D, including beta-cell dysfunction, insulin resistance, imbalance in redox homeostasis, and impairment of incretin signaling; from these studies, multiple disease-associated gene polymorphisms have been identified [10,11,12,13,14]. The gene discussed is GCG; the disease is Insulin resistance.